Prudential Financial’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,774
Closed -$894K 2445
2025
Q4
$894K Sell
8,774
-47,146
-84% -$3.79M ﹤0.01% 1633
2025
Q3
$3.06M Buy
55,920
+21,200
+61% +$1.06M ﹤0.01% 1163
2025
Q2
$1.85M Buy
34,720
+24,951
+255% +$1.27M ﹤0.01% 1421
2025
Q1
$423K Buy
9,769
+2,680
+38% +$136K ﹤0.01% 1894
2024
Q4
$398K Sell
7,089
-6,055
-46% -$377K ﹤0.01% 1909
2024
Q3
$895K Sell
13,144
-1,275
-9% -$72K ﹤0.01% 1944
2024
Q2
$609K Sell
14,419
-2,061
-13% -$113K ﹤0.01% 2084
2024
Q1
$1.14M Buy
16,480
+714
+5% +$45.2K ﹤0.01% 1751
2023
Q4
$1.17M Buy
15,766
+3,720
+31% +$244K ﹤0.01% 1746
2023
Q3
$822K Sell
12,046
-254,495
-95% -$21.6M ﹤0.01% 1852
2023
Q2
$25M Buy
266,541
+200,771
+305% +$15.7M 0.04% 395
2023
Q1
$2.71M Sell
65,770
-148,166
-69% -$9.52M ﹤0.01% 1143
2022
Q4
$10.6M Buy
213,936
+134,553
+169% +$5.5M 0.02% 614
2022
Q3
$2.63M Buy
79,383
+65,514
+472% +$2.7M ﹤0.01% 1168
2022
Q2
$563K Buy
13,869
+569
+4% +$30.4K ﹤0.01% 2069
2022
Q1
$929K Sell
13,300
-11,069
-45% -$809K ﹤0.01% 1906
2021
Q4
$2.4M Sell
24,369
-999
-4% -$88.2K ﹤0.01% 1425
2021
Q3
$2.74M Buy
25,368
+5,679
+29% +$600K ﹤0.01% 1295
2021
Q2
$2.45M Buy
19,689
+2,949
+18% +$352K ﹤0.01% 1380
2021
Q1
$2.21M Buy
16,740
+4,429
+36% +$606K ﹤0.01% 1412
2020
Q4
$1.63M Buy
12,311
+3,371
+38% +$408K ﹤0.01% 1509
2020
Q3
$912K Buy
8,940
+1,937
+28% +$167K ﹤0.01% 1686
2020
Q2
$609K Sell
7,003
-39,375
-85% -$3.15M ﹤0.01% 1844
2020
Q1
$2.69M Sell
46,378
-10,699
-19% -$869K 0.01% 1209
2019
Q4
$5.28M Buy
57,077
+49,052
+611% +$4.31M 0.01% 1100
2019
Q3
$725K Buy
8,025
+75
+0.9% +$8.54K ﹤0.01% 1946
2019
Q2
$939K Buy
7,950
+673
+9% +$67.8K ﹤0.01% 1899
2019
Q1
$630K Sell
7,277
-342
-4% -$29.1K ﹤0.01% 2024
2018
Q4
$480K Sell
7,619
-41,107
-84% -$2.82M ﹤0.01% 2011
2018
Q3
$3.85M Sell
48,726
-31,801
-39% -$2.07M 0.01% 1297
2018
Q2
$4.82M Buy
80,527
+1,548
+2% +$83.3K 0.01% 1230
2018
Q1
$3.19M Sell
78,979
-21,690
-22% -$1.06M ﹤0.01% 1354
2017
Q4
$5.29M Buy
100,669
+11,600
+13% +$619K 0.01% 1125
2017
Q3
$4.2M Buy
89,069
+76,910
+633% +$3.1M 0.01% 1223
2017
Q2
$430K Buy
12,159
+1,018
+9% +$31.4K ﹤0.01% 2064
2017
Q1
$263K Buy
11,141
+320
+3% +$6.34K ﹤0.01% 2173
2016
Q4
$145K Hold
10,821
﹤0.01% 2275
2016
Q3
$201K Buy
+10,821
New +$191K ﹤0.01% 2224
2015
Q3
Sell
-9,031
Closed -$269K 2232
2015
Q2
$269K Sell
9,031
-200
-2% -$5.02K ﹤0.01% 2078
2015
Q1
$203K Buy
9,231
+400
+5% +$10.1K ﹤0.01% 2142
2014
Q4
$242K Buy
+8,831
New +$215K ﹤0.01% 2081
2014
Q3
Sell
-18,985
Closed -$323K 2238
2014
Q2
$323K Buy
+18,985
New +$261K ﹤0.01% 2165

Other funds holding EXAS

Prudential Financial's EXAS Position: Q1 2026 in Review

Prudential Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 8,774 shares — an estimated $894K sold.

Prudential Financial first reported a position in EXAS in Q2 2014 and held it in 42 quarters. The position peaked at $25M in Q2 2023. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Prudential Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Prudential Financial sold 8,774 Exact Sciences shares in Q1 2026, an estimated $894K.
  • Prudential Financial first reported a position in Exact Sciences in Q2 2014 and held it in 42 quarters.
  • Prudential Financial's Exact Sciences position peaked at $25M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.